Filing Flows

Filing Flows › Avita Medical (RCEL) › Next earnings date

Avita Medical (RCEL) earnings: beat the estimate

Avita Medical (RCEL) reported on Nov 5, 2026 and beat the EPS estimate: −$0.29 against −$0.29 (+1.8%). Revenue was $26.1M for Q3 2026, +53% year over year. It beat the EPS estimate in 60% of the quarters on record.

Last result+1.8% vs estimate
Beat rate60%

The last report

Avita Medical reported revenue of $26.1M for the third quarter 2026 (+53% Y/Y), net loss $6.2M. How it makes money → · Every quarter →

Avita Medical: EPS against the estimate, last 5 reportsAvita Medical: EPS against the estimate, last 5 reportsEstimateReported−$0.46−$0.71Nov 25−$0.55−$0.54Feb 26−$0.38−$0.48May 26−$0.39−$0.36Aug 26−$0.29−$0.29Nov 26
Latest (Nov 26): Estimate −$0.29, Reported −$0.29.

Avita Medical's latest quarter

Avita Medical, Q3 2026: revenue $26.1M (+53% year over year), operating margin -10.1%, net loss $6.2M, operating cash flow −$710K. The chart follows the revenue to costs, profit and cash.

Questions

Did Avita Medical beat earnings?

Avita Medical (RCEL) reported on Nov 5, 2026 and beat the EPS estimate: −$0.29 against −$0.29 (+1.8%).

When does RCEL report earnings?

The next date is not set yet.

Does Avita Medical usually beat earnings?

It beat the consensus EPS estimate in 60% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.